An observational study in Extracorporeal Life Support, Neurodevelopment and Neonate, sponsored by Children's Hospital of Fudan University. Withdrawn. Open to participants aged 1 Hour to 1 Month. Per ClinicalTrials.gov, last updated 2024-01-16.
Sponsored by Children's Hospital of Fudan University · Observational
Descriptive study of two-year follow-up outcomes of surviving neonates who are enrolled in the Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS) from 2022 to 2024.
This study aims to describe the six -month, one-year and two-year neurodevelopmental outcomes of survivors of neonatal ECLS treatment in the Chi-NELS. The study population will be neonates who receive ECLS support within 28 days of life and are enrolled in the Chi-NELS. These infants will be prospectively followed for two years. Mortality, growth, and neurodevelopmental outcomes will be assessed at six months, one year and two years.
Children's Hospital of Fudan University is the lead sponsor of 262 studies on the registry; 92 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Neonates who receive ECLS support within 28 days of life and survive to the first discharge.
Exclusion Criteria:
Mortality or severe/moderate neurodevelopmental delay at two-year old
It is a binary variable (1/0). If mortality or severe/moderate neurodevelopmental delay occur in the participent, the value of this varible is 1.
Time frame: At two-year old
Body weight of infants at six months
Time frame: At six months
Length of infants at six months
Time frame: At six months
Head circumference of infants at six months
Time frame: At six months
Body weight of infants at one year old
Time frame: At one year old
Length of infants at one year old
Time frame: At one year old
Head circumference of infants at one year old
Time frame: At one year old
Body weight of infants at two years old
Time frame: At two years old
Length of infants at two years old
Time frame: At two years old
Head circumference of infants at two years old
Time frame: At two years old
Severe/moderate neurodevelopmental delay at six months
Proportion of infants with severe/moderate neurodevelopmental delay according to the development scale
Time frame: At six months
Severe/moderate neurodevelopmental delay at one year old
Proportion of infants with severe/moderate neurodevelopmental delay according to the development scale
Time frame: At one year old
Severe/moderate neurodevelopmental delay at two years old
Proportion of infants with severe/moderate neurodevelopmental delay according to the development scale
Time frame: At two years old
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is withdrawn, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Fudan University